{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:24:38Z","timestamp":1794695078948,"version":"4.9.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neuromuscular diseases (NMDs) are rare, progressive conditions that require lifelong, multidisciplinary care. Advances in diagnosis and treatment have increased survival into adulthood, making the transition from paediatric to adult care a critical stage of its management. However, evidence suggests that transition practices remain inconsistent across Europe. This study aimed to map and evaluate the current transition practices for patients with NMDs across Europe.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional survey was conducted by the European Reference Network for Rare Neuromuscular Diseases (ERN EURO-NMD) to assess current transition practices across European healthcare providers (HCPs). Sixty-seven healthcare professionals from 20 countries participated. The survey explored training provision, transition structures, professional involvement, timing, psychosocial support, and perceived barriers. Both descriptive and thematic analyses were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Only 29.9% of respondents reported structured transition protocols, and fewer than one in five (17,9%) had received formal training in transition care. The age to initiate transition was reported for most centres at 17\u201318 years, even though most clinicians identified 15\u201316 years as the ideal starting point. Multidisciplinary collaboration was present in some centres but was inconsistently implemented. Barriers included insufficient staff, lack of funding, inadequate adult care services, and poor inter-team communication. Post-transfer feedback to paediatric teams was limited. Despite these challenges, 59.7% of respondents believed that ERN EURO-NMD could facilitate improvement in transition care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Transition care for patients with NMDs in Europe remains fragmented and under-resourced. To ensure continuity and improve outcomes, structured, multidisciplinary transition models are needed. A European roadmap, coordinated by ERN EURO-NMD, could harmonise practices, support professional training, and guide policy development across member states.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04144-x","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T13:03:50Z","timestamp":1765285430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transition from childhood to adulthood in neuromuscular disorders: results from the ERN EURO-NMD survey"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1329-9131","authenticated-orcid":false,"given":"Teresinha","family":"Evangelista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Handberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sejersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ros","family":"Quinlivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Masingue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Quijano-Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Atalaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schara-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristl G.","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"4144_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.seizure.2022.07.006","volume":"101","author":"RJM Goselink","year":"2022","unstructured":"Goselink RJM, Olsson I, Malmgren K, Reilly C. Transition to adult care in epilepsy: A systematic review. Seizure. 2022;101:52\u20139.","journal-title":"Seizure"},{"key":"4144_CR2","doi-asserted-by":"crossref","unstructured":"Sandquist M, Davenport T, Monaco J, Lyon ME. The transition to adulthood for youth living with rare diseases. Children. 2022;9(5).","DOI":"10.3390\/children9050710"},{"issue":"Suppl 2","key":"4144_CR3","first-page":"A8","volume":"7","author":"Rodger Sunil SB Lochm\u00fcller Hanns","year":"2012","unstructured":"Rodger Sunil SB Lochm\u00fcller Hanns. Transition from childhood to adulthood in Duchenne muscular dystrophy (DMD). OJRD. 2012;7(Suppl 2):A8.","journal-title":"OJRD"},{"key":"4144_CR4","doi-asserted-by":"crossref","unstructured":"Fleischer M, Coskun B, Stolte B, Della-Marina A, K\u00f6lbel H, Lax H et al. Essen transition model for neuromuscular diseases. Neurol Res Pract. 2022;4(1).","DOI":"10.1186\/s42466-022-00206-8"},{"issue":"4","key":"4144_CR5","first-page":"188","volume":"41","author":"G Accogli","year":"2022","unstructured":"Accogli G, Ferrante C, Fanizza I, Oliva MC, Gallo I, De Rinaldis M, et al. Neuromuscular disorders and transition from pediatric to adult care in a multidisciplinary perspective: a narrative review of the scientific evidence and current debate. Acta Myol Myopathies Cardiomyopathies Off J Mediterr Soc Myol. 2022;41(4):188\u2013200.","journal-title":"Acta Myol Myopathies Cardiomyopathies Off J Mediterr Soc Myol"},{"issue":"4","key":"4144_CR6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/mus.28468","volume":"72","author":"C Wozow","year":"2025","unstructured":"Wozow C, Mosher K. Transitions from pediatric to adult neuromuscular care: A practical guide. Muscle Nerve. 2025;72(4):558\u201365.","journal-title":"Muscle Nerve"},{"key":"4144_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejpn.2025.01.004","volume":"54","author":"D Castro","year":"2025","unstructured":"Castro D, Sejersen T, Bello L, Buccella F, Cairns A, Carranza-del R\u00edo J, et al. Transition of patients with Duchenne muscular dystrophy from paediatric to adult care: an international Delphi consensus study. Eur J Paediatr Neurol. 2025;54:130\u20139.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"4144_CR8","first-page":"1007","volume":"45","author":"L Nanetti","year":"2024","unstructured":"Nanetti L, Kearney M, Boesch S, Stovickova L, Ortigoza-Escobar JD, Macaya A, et al. Child-to-adult transition: a survey of current practices within the European reference network for rare neurological diseases (ERN-RND). Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2024;45(3):1007\u201316.","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"issue":"6","key":"4144_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/archdischild-2014-307423","volume":"100","author":"A Nagra","year":"2015","unstructured":"Nagra A, McGinnity PM, Davis N, Salmon AP. Implementing transition: ready steady go. Arch Dis Child - Educ Pract Ed. 2015;100(6):313\u201320.","journal-title":"Arch Dis Child - Educ Pract Ed"},{"key":"4144_CR10","doi-asserted-by":"crossref","unstructured":"Lupu M, Marcu MA, Epure DA, Vladacenco OA, Severin EM, Teleanu RI. Lost in Transition: Challenges in the Journey from Pediatric to Adult Care for a Romanian DMD Patient. Healthc Switz. 2025;13(7).","DOI":"10.3390\/healthcare13070830"},{"key":"4144_CR11","unstructured":"EURORDIS. Integrated care for rare diseases: Bridging the gap to improve the lives of 30 million people in Europe. 2024; Available from: https:\/\/www.eurordis.org\/publications\/integrated-care-for-rare-diseases-bridging-the-gap-to-improve-the-lives-of-30-million-people-in-europe\/"},{"key":"4144_CR12","doi-asserted-by":"crossref","unstructured":"Crowley R, Wolfe I, Lock K, McKee M. Improving the transition between paediatric and adult healthcare: a systematic review. Arch Dis Child. 2011 June;96(6):548\u2013548.","DOI":"10.1136\/adc.2010.202473"},{"issue":"1","key":"4144_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1542\/peds.2004-1321","volume":"115","author":"JG Reiss","year":"2005","unstructured":"Reiss JG, Gibson RW, Walker LR. Health care transition: Youth, Family, and provider perspectives. Pediatrics. 2005;115(1):112\u201320.","journal-title":"Pediatrics"},{"key":"4144_CR14","unstructured":"The European Health Report. 2021: Taking stock of the health-related Sustainable Development Goals in the COVID-19 era with a focus on leaving no one behind. Copenhagen: World Health Organization, Regional Office for Europe; 2022."},{"key":"4144_CR15","unstructured":"de Santis M, Castro R. INTEGRATED CARE [Internet]. [cited 2025 Aug 7]. Available from: https:\/\/www.rd-action.eu\/wp-content\/uploads\/2018\/09\/INTEGRATED-CARE.pdf"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04144-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04144-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04144-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:05:08Z","timestamp":1768359908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04144-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4144"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04144-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RQ: Honoraria for lectures: PTCbio, Sarepta, Sanofi genzyme, Biogen, Santhera. Participation in data monitoring committees and advisory boards: Roche, TRiNDS, PTCbio, Sarepta, Santhera. PI in clinical trials for PTCbio, Edgewise, Dynacure, unrelated to the current work. TS is recipient of research grant from Pfizer, and honoraria received for lectures or consultancy from Biogen, Novartis, PTC Therapeutics, Sarepta Therapeutics, Pfizer, Roche, and Italfarmaco, unrelated to the current work. KGC received speaker\/advisory board honoraria from Alexion, Alnylam, Amgen, Amicus, argenx, AstraZeneca, Biogen, Edgewise, Ipsen Pharma, Janssen Pharmaceutics, Lupin, Pfizer, Roche, Sanofi-Genzyme, UCB; and is recipient of research funding by CSL Behring, Alnylam, Pfizer, Sanofi-Genzyme, Vertex, Biogen and Roche, unrelated to the current work. The other authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}